- Home
- HUIZ vs VTVT Comparison
HUIZ vs VTVT Comparison
Compare HUIZ & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- VTVT
- Stock Information
- Founded
- HUIZ 2006
- VTVT 2015
- Country
- HUIZ China
- VTVT United States
- Employees
- HUIZ N/A
- VTVT N/A
- Industry
- HUIZ Specialty Insurers
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- VTVT Health Care
- Exchange
- HUIZ Nasdaq
- VTVT Nasdaq
- Market Cap
- HUIZ 33.3M
- VTVT 38.8M
- IPO Year
- HUIZ 2020
- VTVT 2015
- Fundamental
- Price
- HUIZ $2.57
- VTVT $17.50
- Analyst Decision
- HUIZ
- VTVT Strong Buy
- Analyst Count
- HUIZ 0
- VTVT 1
- Target Price
- HUIZ N/A
- VTVT $35.00
- AVG Volume (30 Days)
- HUIZ 18.7K
- VTVT 46.4K
- Earning Date
- HUIZ 03-24-2025
- VTVT 05-08-2025
- Dividend Yield
- HUIZ N/A
- VTVT N/A
- EPS Growth
- HUIZ N/A
- VTVT N/A
- EPS
- HUIZ N/A
- VTVT N/A
- Revenue
- HUIZ $171,105,205.00
- VTVT $1,017,000.00
- Revenue This Year
- HUIZ N/A
- VTVT N/A
- Revenue Next Year
- HUIZ $16.92
- VTVT N/A
- P/E Ratio
- HUIZ N/A
- VTVT N/A
- Revenue Growth
- HUIZ 4.46
- VTVT N/A
- 52 Week Low
- HUIZ $2.15
- VTVT $12.12
- 52 Week High
- HUIZ $10.58
- VTVT $29.19
- Technical
- Relative Strength Index (RSI)
- HUIZ 30.27
- VTVT 50.68
- Support Level
- HUIZ $2.61
- VTVT $16.40
- Resistance Level
- HUIZ $2.68
- VTVT $17.86
- Average True Range (ATR)
- HUIZ 0.17
- VTVT 1.98
- MACD
- HUIZ -0.06
- VTVT -0.05
- Stochastic Oscillator
- HUIZ 6.06
- VTVT 21.83
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.